Coeliac disease: the abolition of gliadin toxicity by enzymes from Aspergillus niger.
نویسندگان
چکیده
1. Gliadin from which carbohydrate was removed by treatment with carbohydrase from Aspergillus niger was fed to three coeliac patients in remission. 2. Xylose absorption, mucosal morphology and brush-border enzymes were used to assess the toxicity of the carbohydrase-treated gliadin. 3. Gliadin treated with carbohydrases did not damage the intestinal mucosa of the coeliac patients. 4. The primary structure of the gliadin proteins was not altered by the enzyme treatment.
منابع مشابه
D-Gluconate Transport in Bacillus subtilis
and non-uniformity of the oligosaccharides themselves, would indicate that the toxicity is a property of a number of molecules. For this reason large-scale chromatographic techniques were avoided since they would result in a distribution of toxicity across the chromatographic profile. Instead the role of carbohydrate was investigated by the selective removal of the sugar residues glycosidic lin...
متن کاملBreakdown of gliadin peptides by intestinal brush borders from coeliac patients.
The 'missing peptidase' hypothesis to explain the aetiology of coeliac disease has never been satisfactorily resolved and recent reports suggest that coeliac brush borders may have depressed levels of specific peptidase enzymes. It has been inferred from these studies that the subsequent brush border digestion of gliadin peptides may therefore be defective. In this present study a sensitive flu...
متن کاملRe-evaluation of the techique of organ culture for studying gluten toxicity in coeliac disease.
In vitro cytotoxicity of four different gluten fractions was tested in organ culture for up to 48 hours using flat intestinal biopsies from children with coeliac disease. The fractions were (1) a peptic-tryptic digest of gliadin containing a moderate amount of alpha-gliadin, (2) a peptic-tryptic digest of gluten (Frazer fraction III) froma strain of wheat with a high content of alpha-gliadin, (...
متن کاملOral proteases: a new approach to managing coeliac disease.
A life-long but constraining gluten-free diet is the only treatment currently available for coeliac disease. The human gastrointestinal tract does not possess the enzymatic equipment to efficiently cleave the gluten-derived proline-rich peptides driving the abnormal immune intestinal response in patients with coeliac disease. Oral therapy by exogenous prolylendopeptidases able to digest ingeste...
متن کاملGliadin uptake in human enterocytes. Differences between coeliac patients in remission and control individuals.
The pepsin trypsin digest of the wheat prolamin gliadin (PT-gliadin) is deleterious to the small intestinal mucosa of coeliac patients. The handling of PT-gliadin by the intestinal epithelium in coeliac patients in remission and control individuals was investigated by in vivo instillation of PT-gliadin. The uptake of PT-gliadin was monitored by immunofluorescence microscopy of intestinal biopsy...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Clinical science and molecular medicine
دوره 53 1 شماره
صفحات -
تاریخ انتشار 1977